Quick answer

The large-scale answer is settled: trials and pooled reviews covering hundreds of thousands of adults find multivitamins do not reduce mortality, cardiovascular disease or cancer in generally nourished populations — the editorial verdict "enough is enough" summarized a decade of it. A newer wrinkle: the COSMOS trials found small memory/cognition benefits in older adults over 2–3 years — modest, awaiting longer confirmation, and the one honest bright spot. Genuine use-cases are specific: pregnancy (prenatal with folic acid), restricted or very-low-calorie diets, vegans (B12 at minimum), post-bariatric patients (mandatory), heavy alcohol use, malabsorption, and low-appetite elderly. A basic multi is cheap and low-risk; it is insurance against a poor diet, not enhancement of a decent one.

What the big trials actually found

Multivitamins are the most-taken supplement on earth, and among the most-tested. The scoreboard from the major evidence:

  • Mortality, heart disease, cancer: the Physicians' Health Study II (14,000+ men, 11 years) found no cardiovascular or mortality benefit (a small ~8% total-cancer reduction in that trial stands mostly unreplicated); pooled analyses and the US Preventive Services Task Force reviews conclude insufficient evidence of benefit for supplementation in nourished adults — and actively recommend against beta-carotene and vitamin E for prevention. The famous 2013 editorial title — "Enough is enough: stop wasting money on vitamin and mineral supplements" — annoyed the industry precisely because it summarized the data fairly.
  • The observational mirage: multivitamin users are healthier — they also exercise more, smoke less and see doctors more; adjusted analyses and the trials above show the pill wasn't the ingredient. The same healthy-user physics that inflated vitamin D's panacea decade built this aisle.
  • The COSMOS wrinkle — the FAQ's honest accounting: small, replicated short-term cognitive benefits in older adults, the first daylight the category has seen, sized at "interesting," not "protective."

Who genuinely benefits

The list is real and specific, per the FAQ's targeted table: pregnancy and preconception (folic acid's neural-tube evidence is among nutrition's strongest), vegans and near-vegans (B12 above all), post-bariatric surgery (lifelong, prescribed), very-low-calorie or heavily restricted diets, malabsorption and heavy alcohol use, low-appetite elderly, and anyone with a tested deficiency — where the specific nutrient at correction dose beats a shotgun multi anyway. Outside the list, the multi is answering a question food already answered.

The honest framing

A multivitamin is insurance against dietary gaps, not enhancement of adequacy — and like all insurance, its value tracks the risk insured. A varied diet makes the premium a waste; a chaotic season of life makes a basic tested multi a defensible backstop while the diet gets fixed; and no version of it touches the outcomes on the label's aspirational aura — energy for the un-fatigued diagnosis, immunity per that aisle's verdict, longevity per the trials above. The per-decision playbook: check the diet honestly, test where symptoms or risk suggest, supply gaps by name, and if defaulting to a multi anyway — the FAQ's basic-iron-free-tested spec, at pharmacy prices, with expectations set by a decade of large trials that looked hard for magic and priced the policy at "peace of mind, sold separately from outcomes."

Frequently asked questions

If it "can't hurt," why not take one anyway?

A basic multi at ~100% DVs mostly can't, which is why the honest verdict is "unnecessary" rather than "dangerous" — the costs are money, false reassurance displacing actual diet quality, and formulation creep: mega-dose versions reintroduce real risks (smokers and beta-carotene's lung-cancer signal; vitamin A over ~3,000 mcg and bone/pregnancy concerns; iron in men and postmenopausal women who shouldn't take it unprescribed). If taking one: basic, iron-free unless indicated, no megadoses, tested brand.

What exactly did the COSMOS memory finding show?

In ~2,200–3,500 older adults per trial arm, a daily multivitamin modestly outperformed placebo on memory and global cognition over 2–3 years — roughly "1–2 years less cognitive aging" by the authors' framing, replicated across three COSMOS sub-studies. Honest sizing: small effects, older populations, surrogate cognitive scores, funding involving a manufacturer, and no dementia-prevention claim available. It moved the multivitamin from "nothing anywhere" to "possibly something small here" — the memory-supplements page ranks it in that context.

Are gummy or "whole-food" multivitamins better?

Gummies are worse on average — fewer nutrients (minerals don't gummy well), sugar, and the format's documented label-accuracy problems. "Whole-food" and "food-based" multis sell a naturalness premium without outcome evidence behind it. The boring answer again: a basic tablet from a third-party-tested brand, or better, the actual foods the marketing is imitating.

What should specific groups actually take instead of a generic multi?

Targeted beats general wherever a need is known: pregnancy → prenatal with 400+ mcg folic acid (started before conception) and iron as advised; vegans → B12 non-negotiably, with D, iodine, omega-3 considered; post-bariatric → the lifelong prescribed regimen, not a retail multi; over-70 with small appetites → a multi plus specific D/B12 attention is reasonable; diagnosed deficiencies → the specific nutrient at correction dose, retested. The pattern: test or reason from the diet, then supply the gap by name.

References

  1. NIH Office of Dietary Supplements. Multivitamin/mineral Supplements — Fact Sheet for Health Professionals (2023). https://ods.od.nih.gov/factsheets/MVMS-HealthProfessional/
  2. National Center for Complementary and Integrative Health (NCCIH). Diabetes and Dietary Supplements: What You Need To Know (2021). https://www.nccih.nih.gov/health/diabetes-and-dietary-supplements-what-you-need-to-know
About this article

This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.